advisorsecurities master

ORGOOrganogenesis Holdings Inc. Class A Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
19723
Ticker
ORGO
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2016-11-29
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
ORGO

Detail

Enriched 2026-08-14 20:47

Market cap
$232,900,931.88
Shares outstanding (class)
128,674,548
Shares outstanding (weighted)
128,674,548
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
854
Location
CANTON, MA
Description

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data